Letters to the Editor Open access

Comments on “Comparison of immediate withdrawal and stepwise reduction in duration of non-invasive ventilation in chronic obstructive pulmonary disease patients presenting with acute hypercapnic respiratory failure”

Authors

Published
6 November 2023
Section
Letters to the Editor
DOI
10.4081/monaldi.2023.2828

Abstract

Dear Editor, 
The recent study published by Purohit et al. provides new evidence on the safety of immediate withdrawal of non-invasive ventilation in chronic obstructive pulmonary disease patients admitted with acute hypercapnic respiratory failure after recovery...

Keywords

References

  1. Purohit S, Madan M, Kumar R, et al. Comparison of immediate withdrawal and stepwise reduction in duration of non-invasive ventilation in chronic obstructive pulmonary disease patients presenting with acute hypercapnic respiratory failure. Monaldi Arch Chest Dis 2023;94:2755.
  2. Rochwerg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J 2017;50:1602426.
  3. Chawla R, Dixit SB, Zirpe KG, et al. ISCCM guidelines for the use of non-invasive ventilation in acute respiratory failure in adult ICUs. Indian J Crit Care Med 2020;24:S61-81.
  4. Macrea M, Oczkowski S, Rochwerg B, et al. Long-term noninvasive ventilation in chronic stable hypercapnic chronic obstructive pulmonary disease. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med 2020;202:e74-87.
  5. Suri TM, Suri JC. A review of therapies for the overlap syndrome of obstructive sleep apnea and chronic obstructive pulmonary disease. FASEB Bioadv 2021;3:683-93.
  6. Global Initiative Chronic Lung Obstructive Disease (GOLD). Global strategy for prevention, diagnosis and management of COPD: 2023 report. Accessed: 20 October 2023. Available from: https://goldcopd.org/2023-gold-report-2/.

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.

PlumX Metrics

License

Copyright (c) 2023 The Author(s)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.